Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Clinical Data
  • Pivotal trial of Moderna’s H5N1 bird flu jab gets underway
  • Clinical Data

Pivotal trial of Moderna’s H5N1 bird flu jab gets underway

Pharmaphorum

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu have received shots in the UK and US.

Clinical DataInfectious DiseaseRead full story

pharminent April 22, 2026 (Last updated: April 22, 2026)

Pharmaphorum

The first volunteers in a large-scale trial of Moderna’s mRNA-based vaccine against bird flu have received shots in the UK and US.

Clinical DataInfectious DiseaseRead full story

Post navigation

Previous: BioAegis and Prenosis partner for inflammatory disease therapies
Next: New data build case for Roche’s oral BTK drug for MS

Related Stories

  • Clinical Data

Novo Nordisk starts trialing lower maintenance doses of oral Wegovy

pharminent August 21, 2026
  • Clinical Data

Cancer vaccine win restores Wall Street’s faith in Moderna

pharminent August 20, 2026
  • Clinical Data

New Taiho, Cullian data heats up lung cancer drug battle

pharminent August 13, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.